NL-OMON34105尚未招募不适用
Measurement of lithium pharmacokinetics with the Medimate Multireader® in cluster headache patients - Measurement of lithium pharmacokinetics in cluster headache patients
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 22
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Diagnosed with cluster headache according to The International Classification of Headache Disorders, 2nd Edition. The patients should have a stable lithium intake for at least 3 weeks.
排除标准
- •Patients with significant renal disease which may interfere with the study, or patients with other significant neurological or disabling diseases than CH, are excluded from this study.
研究者
相似试验
招募中
不适用
Medimate Lithium Analyzer Validation ResearchNL-OMON33830medimate bv10
招募中
不适用
Measurement of the concentrations of lithium, sodium, potassium and creatinine in the saliva of patients with treatment-resistant depression.F32F31Depressive episodeBipolar affective disorderDRKS00031566Medizinische Hochschule Brandenburg40
招募中
不适用
Observational study for measuring lithium concentrations in venous blood and salivaF32F31Depressive episodeBipolar affective disorderDRKS00030846Zentralinstitut für Seelische Gesundheit20
招募中
不适用
Comparison of outcome between domestic and foreign-made ceramic materials in dental caries treatment and esthetic tooth restoratioKCT0006131Yonsei University Health System, Dental Hospital72
进行中（未招募）
不适用
A randomised sequential trial of Lithium in amyotrophic lateral sclerosis - Lithium in ALSAmyotrophic lateral sclerosis (ALS) is a disease characterised by progressive degeneration of motor neurons in brain and spinal cord leading to muscle weakness. ALS can occur at anytime in adulthood. Muscle weakness gradually progresses. Approximately 50% of patients die within 3 years after onset of symptoms, usually as the result of respiratory failure. To date, only one drug, i.e. riluzole, has proven to extend survival in patients with ALS, but only by approximately 3 to 6 months.MedDRA version: 9.1Level: LLTClassification code 10052889Term: ALSEUCTR2008-002110-22-NLProf. dr L.H. van den Berg, UMC-Utrecht